A North American, single-center experience implanting fenestrated atrial devices and atrial flow regulators into a heterogeneous group of pediatric pulmonary hypertension patients

INTRODUCTION: The clinical deterioration commonly experienced by pediatric patients with pulmonary arterial hypertension (PAH) has motivated a shift in the treatment of pulmonary hypertension (PH) through innovations in surgical salvage interventions. The Occlutech fenestrated atrial septal defect (...

Descripción completa

Detalles Bibliográficos
Autores principales: Youssef, David Edward, Averin, Konstantin, Richards, Susan, Sheppard, Catherine, Seaman, Cameron, Pietrosanu, Matthew, Bates, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905673/
https://www.ncbi.nlm.nih.gov/pubmed/36762281
http://dx.doi.org/10.3389/fped.2023.1073336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905673/
https://www.ncbi.nlm.nih.gov/pubmed/36762281
http://dx.doi.org/10.3389/fped.2023.1073336

Ejemplares similares